L-838,417
Tocris Bioscience | Catalog # 3250
Key Product Details
Description
Product Description
L-838,417 is a subtype-selective GABAA receptor partial agonist. Selectively binds to α1, α2, α3 and α5 subunits (Ki values are 0.79, 0.67, 0.67 and 2.25 nM respectively) but displays no efficacy at α1 (α1-sparing). Exhibits non-sedative anxiolytic, antinociceptive and anti-inflammatory activity in vivo.Licensing Information
Manufactured and sold under license from Merck & Co., Inc. for use solely for preclinical research purposes (ie: not for administration to or other use in humans)
Product Specifications for L-838,417
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 19.97 | 50 |
Preparing Stock Solutions for L-838,417
The following data is based on the product molecular weight 399.40.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 5.01 mL | 25.04 mL | 50.08 mL |
| 2.5 mM | 1.00 mL | 5.01 mL | 10.02 mL |
| 5 mM | 0.50 mL | 2.50 mL | 5.01 mL |
| 25 mM | 0.10 mL | 0.50 mL | 1.00 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 11 publications citing the usage of this product.
- Soderhielm Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABAA receptors. Biochem.Pharmacol. 2018 PMID: 30121248
- McMahon and France Differential behavioural effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys. Br.J.Pharmacol. 2006 PMID: 16331290
- Knabl Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 2008 PMID: 18202657
- McCabe Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour. Neuropharmacology 2004 PMID: 14680756
Product Documents for L-838,417
Product Specific Notices for L-838,417
For research use only
Related Research Areas
Citations for L-838,417
Customer Reviews for L-838,417
There are currently no reviews for this product. Be the first to review L-838,417 and earn rewards!
Have you used L-838,417?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review